Enteropathy-Associated T-Cell Lymphoma - 18 Studies Found
Completed |
: Study of MLN8237 in Participants With Advanced Hematological Malignancies :
|
Completed |
: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma :
: 2009-05-11 : Drug: panobinostat and bortezomib oral panobinostat 30 mg 3 times per week AND intravenous bortezomib 1. |
Recruiting |
: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma :
|
Recruiting |
: MAgnetic Resonance Imaging in COeliac Disease :
: Other: Gluten free diet Patients will follow a gluten free diet |
Terminated |
: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma :
: 2008-05-02 :
|
Terminated |
: Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma : Lymphoma : 2008-12-16 :
|
Completed |
: SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma : Lymphoma : 2008-11-06 :
|